Personal Therapy Comfort Settings Pilot Clinical Study
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Device: continuous positive airway pressure (CPAP)
- Registration Number
- NCT05376137
- Lead Sponsor
- ResMed
- Brief Summary
350 participants will be enrolled in this study. The target population are patients newly diagnosed with OSA and starting CPAP treatment.
User accessible customizable comfort settings (Response setting, expiratory pressure relief (EPR) on/off and EPR level, and Ramp) will be set to either default (control group), or personalized for that participant (active treatment group).
Usage will be recorded for the first 1 month of CPAP treatment, to determine if customizing comfort settings can improve CPAP compliance
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- Patients willing to give written informed consent
- Patients who can read and comprehend English
- Patients who are ≥ 18 years of age
- Patients newly diagnosed with OSA and indicated for CPAP therapy.
-
Patients who have previously used PAP therapy
-
Patients who require a bilevel device
-
Patients who are or may be pregnant
* Patients who are unable to attend follow up appointments
-
Patients with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury
-
Patients believed to be unsuitable for inclusion by the researcher
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Default comfort settings continuous positive airway pressure (CPAP) Comfort settings will be set to default (out of the box setttings) Personalized Therapy Comfort Settings continuous positive airway pressure (CPAP) Comfort settings will be personalized to each user
- Primary Outcome Measures
Name Time Method Comparison of treatment continuance between the control group and active treatment group. 4 weeks after commencement of CPAP Patients who drop off treatment (stop using CPAP treatment) in each group will be compared after 1.5 months of CPAP treatment.
- Secondary Outcome Measures
Name Time Method Mask leak 4 weeks after commencement of CPAP Mask leak will be compared between the two groups
comparison of compliance between the control group and active treatment group 4 weeks after commencement of CPAP Usage will be compared between the two groups
Treatment efficacy 4 weeks after commencement of CPAP Residual Apnea-hypopnea index will be compared between the two groups
Settings changes 4 weeks after commencement of CPAP Number of comfort settings changes will be compared between the two groups
Ad hoc contacts 4 weeks after commencement of CPAP Number of ad hoc contacts between participants and clinicians will be compared between the two groups
Trial Locations
- Locations (1)
ResMed Centre for Healthy Sleep
🇦🇺Bella Vista, New South Wales, Australia